SELECTED RECENT PUBLICATIONS

1996

Phelan CM, Rebbeck TR, Weber BL, Devilee P, Lynch HT, Lenoir GM, Stratton MR, Easton DF, Ruttledge MH, Larsson C, Goldgar DE, Narod SA (1996) Ovarian Cancer Risk in BRCA1 Carriers is Modified by the HRAS1 Variable Number of Tandem Repeats (VNTR) Locus. Nature Genetics, 12:309-311.

Maris JM, Kyemba SM, Rebbeck TR, White PS, Sulman EP, Jensen SJ, Allen C, Biegel JA, Yanofsky RA, Feldman GL, Brodeur GM (1996) Familial Predisposition to Neuroblastoma Does Not Map to Chromosome Band 1p36. Cancer Research, 56(15):3421-3425.

Rebbeck TR, Couch FJ, Kant J, Calzone K, DeShano M, Garber JE, Weber BL (1996). Genetic Heterogeneity in Hereditary Breast Cancer: Role of BRCA1 and BRCA2. American Journal of Human Genetics, 59:547-553.

Tonin P, Weber B, Offit K, Couch F, Rebbeck TR, Neuhausen S, Godwin A, Daly M, Wagner-Costalos J, Berman D, Grana G, Fox E, Kane MF, Kolodner RD, Krainer M, Haber DA, Struewing JP, Warner E, Rosen B, Lerman C, Peshkin B, Norton L, Serova O, Foulkes W, Lynch HT, Lenoir GM, Narod SA, Garber JE (1996) Frequency of Recurrent BRCA1 and BRCA2 Mutations in 222 Ashkenazi Jewish Breast Cancer Families. Nature Medicine, 2(11):1179-1183.

Rebbeck TR, Godwin AK, Buetow KH (1996) Variability in Loss of Constitutional Heterozygosity Across Loci and Among Individuals: Association with Candidate Genes in Ductal Breast Carcinoma. Molecular Carcinogenesis, 17:117-125.

Solin LJ, Fox K, August DA, Dershaw DD, Rebbeck TR, Weber BL, Lichter A (1996) Breast Cancer. In: Hoskins WJ, Perez CA, Young RC. Principles and Practices of Gynecologic Oncology, Second Edition. Philadelphia: J.B. Lippincott Co, pp. 1079-1142.

Rebbeck TR, Jordan HA, Schnur RA, Rogatko A (1997) Utility of Linked Markers in Genetic Counseling: Estimating Genetic Carrier Risks in X-Linked Ocular Albinism. American Journal of Medical Genetics, 70(1):58-66.

Couch FJ, DeShano ML, Blackwood MA Calzone K, Stopfer JE, Campeau L, Ganguly A, Jablon L, Cobleigh MA, Hoskins K, Garber JE, Rebbeck TR, Weber BL (1997) A Predicted Probability Model for Presence of Germline BRCA1 Mutations in Breast Cancer Families. New England Journal of Medicine, 336(20):1409-1415.

Rebbeck TR (1997) Molecular Epidemiology of the Human Glutathione-S-Transferase Genotypes GSTM1 and GSTT1 in Cancer Susceptibility. Cancer Epidemiology, Biomarkers and Prevention, 6:733-743.

Maris JM, Kyemba S, Rebbeck TR, White PS, Sulman EP, Jensen SJ, Allen C, Biegel JA, Brodeur GM (1997) Molecular Genetic Analysis of Familial Neuroblastoma. European Journal of Cancer, 33(12):1923-1928.

Pellegrino JE, George RAV, Biegel J, Farlow MR, Gardner K, Caress J, Brown MJ, Rebbeck TR, Bird TD, Chance PF (1997) Hereditary Neuralgic Amyotrophy: Evidence for Genetic Homogeneity and Refined Mapping to Chromosome 17q25. Human Genetics, 101(3): 277-283.

Rebbeck TR, Walker AH, Phelan CM, Godwin AK, Buetow KH, Narod SA, Garber JE, Weber BL (1997) Defining Etiologic Heterogeneity in Breast Cancer Using Genetic Biomarkers. In: Aldaz CM, Gould MN, McLachlan J, Slaga TJ (Eds) Etiology of Breast and Gynecological Cancers. Progress in Clinical and Biological Research, 396:53-62.

Rogatko A, Babb J, Rebbeck TR (1997) Genetic Counseling. In: Armitage P, Colton T. Encyclopedia of Biostatistics, Volume 2. Chichester: John Wiley and Sons, pp. 1672-1674.

Ford D, Easton DF, Stratton M, Narod S, Goldgar D, Devilee P, Bishop DT, Weber BL, Lenoir G, Chang-Claude J, Sobol H, Teare MD, Struewing J, Aarason A, Scherneck S, Peto J, Rebbeck TR, Tonin P, Neuhausen S, Barkadottir R, Eyfjord J, Lynch H, Ponder B, Birch JM, Lindblom A, Stoppa-Lyonnet D, Bignon Y, Borg A, Hamman U, Haites N, Scott R, Maugard-Louboutin A, and The Breast Cancer Linkage Consortium (1998). Genetic Heterogeneity and Penentrance Analysis of the BRCA1 and BRCA2 Genes in Breast Cancer Families. American Journal of Human Genetics, 62(3):676-689.

Rebbeck TR, Rogatko A, Viana MAG (1998). Translation of Genetic Information from Laboratory to Clinic: Use of BRCA1, BRCA2, and N-Acetyl Transferase-2 Genotypes in Breast Cancer Risk Evaluation. Genetic Testing, 1(3):157-164.

Brunet JS, Ghadirian P, Rebbeck TR, Lerman C, Garber JE, Tonin P, Abrahamson J, Foulkes WD, Daly MB, Wagner-Costalas J, Godwin A, Olopade F, Moslehi R, Liede A, Futreal A, Weber BL, Lenoir GM, Lynch HT, Narod SA (1998) The Effect of Smoking on Breast Cancer in BRCA1 and BRCA2 Carriers. Journal of the National Cancer Institute, 90(10):761-766.

Rubin SC, Blackwood MA, Bandera C, Behbakht K, Benjamin I, Rebbeck TR, Boyd J (1998). BRCA1, BRCA2, and HNPCC Gene Mutations in an Unselected Ovarian Cancer Population: Relationship to Family History and Implications for Genetic Testing. American Journal of Obstetrics and Gynecology, 178(4):670-677.

Felix CA, Hosler MR, Slater DJ, Parker RI, Masterson M, Whitlock JA, Rebbeck TR, Nowell PC, Lange BJ (1998) MLL Genomic Breakpoint Distribution within the Breakpoint Cluster Region in De Novo Leukemia in Children. Journal of Pediatric Hematology and Oncology, 20(4):299-308.

Wang-Göhrke S, Rebbeck TR, Besenfelder W, Kreienberg R, Runnebaum IB (1998) p53 Germline Polymorphisms are Associated with an Increased Risk for Breast Cancer in German Women. Anticancer Research, 18:2095-2100.

Rebbeck TR, Jaffe JM, Walker AH, Wein AJ, Malkowicz SB (1998) Modification of Clinical Characteristics of Prostate Cancers by CYP3A4 Genotype. Journal of the National Cancer Institute, 90(16):1225-1229.

Viana MG, Rogatko A, Rebbeck TR (1998) Statistical Assessment of Multi-Valued Diagnostic Tests. Canadian Journal of Statistics, 26(4):101-112.

Walker AH, Jaffe JM, Gunasegaram S, Cummings SA, Huang CS, Chern HD, Olopade OI, Weber BL, Rebbeck TR (1998) Characterization of an Allelic Variant in the Nifedipine-Specific Element of CYP3A4: Ethnic Distribution and Implications for Prostate Cancer Risk. Human Mutation, 12(4):289-293.

Felix CA, Walker AH, Lange B, Williams TM, Winick NJ, Cheung N-KV, Lovett BD, Nowell P, Blair IA, Rebbeck TR (1998) Association of CYP3A4 Genotype with Treatment-Related Leukemia. Proceedings of the National Academy of Sciences (USA), 95:13176-13181.

Arepally G, Rebbeck TR, Song WJ, Gilliland G, Maris JM, Poncz M (1998) Evidence for Genetic Homogeneity in a Familial Platelet Disorder with predisposition to Acute Myelogenous Leukemia. Blood, 92: (7) 2600-2602.

Margolis DJ, Halpern AC, Rebbeck T, Berwick M (1998) External validity of a melanoma prognostic model. Archives of Dermatology, 134:1597-1601.

Narod SA, Risch H, Moslehi R, Neuhausen S, Moller P, Olsson H, Provencher D, Radice P, Evans G, Bishop S, Brunet JS, Easton D, and the Hereditary Ovarian Cancer Clinical Study Group (1998) Oral Contraceptive Use Reduces the Risk of Hereditary Ovarian Cancer. New England Journal of Medicine, 339:424-8.

Loh E, Rebbeck TR, Mahoney PD, Chen F, Swain JL, Holmes EW (1999) AMPD1 Genotype Predicts Survival in Patients with Heart Failure. Circulation, 99:1422-1425.

Carroll BT, Couch FJ, Rebbeck TR, Weber BL (1999) Polymorphisms in PTEN in Breast Cancer Families. American Journal of Medical Genetics, 36:64-96.

Rebbeck TR, Kantoff PA, Krithivas K, Godwin AK, Daly MB, Narod SA, Garber JE, Weber BL, Brown M (1999) Modification of BRCA1-Associated Breast Cancer Penetrance by Androgen Receptor CAG Repeat Length Variants. American Journal of Human Genetics, 64:1371-1377.

Walker AH, White DL, Jaffe JM, Kanetsky PA, Rebbeck TR (1999) Collection of Genomic DNA by Buccal Swabs for PCR-Based Biomarker Assays. Environmental Heath Perspectives, 107(7):3-7.

Rebbeck TR, Levin AM, Eisen A, Snyder C, Watson P, Cannon-Albright L, Isaacs C, Olopade O, Garber JE, Godwin AK, Daly MB, Narod S, Neuhausen S, Lynch HT, Weber BL (1999) Reduction in Breast Cancer Risk Following Bilateral Prophylactic Oophorectomy in BRCA1 Mutation Carriers. Journal of the National Cancer Institute, 91(17):1475-1479.

Amirimani B, Walker AH, Weber BL, Rebbeck TR (1999) Response to Ando et al. Re: Modification of Clinical Presentation of Prostate Tumors by a Novel Genetic Variant in CYP3A4 (letter). Journal of the National Cancer Institute, 91(18):1588-1590.

Taioli E and the Collaborative Group on Genetic Susceptibility to Environmental Carcinogens (1999) International Collaborative Study on Genetic Susceptibility to Environmental Carcinogens. Cancer Epidemiology, Biomarkers, and Prevention, 8:727-728.

Rebbeck TR (1999) Inherited Genetic Predisposition in Breast Cancer: A Population-Based Perspective. Cancer 86(11 Supplement):2493-2501.

White DL, Rebbeck TR (1999) Using MasterAmp PCR Premixes to Optimize Analysis of High GC Content Genes: PCR Amplification of the Melanocortin-1 Receptor Gene. Epicentre Forum, In Press.

Rebbeck TR (1999) Breast Cancer Risk and Risk Modification in BRCA1 Mutation Carriers. In Perry MC (ed.) ASCO Educational Book, Alexandria, VA: ASCO, p 454-459.

Rebbeck TR (1999) Genetic Susceptibility to Breast Cancer: High Penetrance and Low Penetrance Factors. In Ehrlich M (Ed.) DNA Alterations in Cancer: Genetic and Epigenetic Changes. Natick, MA: BioTechniques Books.

Rebbeck TR (2000) More About: Modification of Clinical Presentation of Prostate Tumors by a Novel Genetic Variant in CYP3A4 (letter). Journal of the National Cancer Institute, 92(10):76.

Jaffe JM, Walker AH, MacBride S, Peschel R, Tomaszewski J, Van Arsdalen K, Wein AJ, Malkowicz SB, Rebbeck TR (2000) Association of SRD5A2 Genotype and Pathologic Characteristics of Prostate Tumors. Cancer Research, 60:1626-1630.

Rebbeck TR, Walker AH, Zeigler-Johnson CM, Weisburg S, Martin A-M, Nathanson KL, Wein AJ, Malkowicz SB (2000) Association of HPC2/ELAC2 Genotypes and Prostate Cancer, American Journal of Human Genetics, 67:1014-1019.

Shih HA, Nathanson KL, Seal S, Collins N, Stratton MR, Rebbeck TR, Weber BL (2000). BRCA1 and BRCA2 mutations in breast cancer families with multiple primary cancers. Clinical Cancer Research, 6(11):4259-64.

Weiss MJ, Guo C, Shusterman S, Hii G, Mirensky TL, White PS, Hogarty MD, Rebbeck TR, Teare D, Urbanek M, Brodeur GM, Maris JM. (2000) Localization of a hereditary neuroblastoma predisposition gene to 16p12-p13. Medical Pediatric Oncology. 35(6):526-30.

Carlini EJ, Raftogianis RB, Wood, TC, Jun F, Zheng W, Rebbeck TR, Weinshilboum RM (2001) Sulfation Pharmacogenetics: SULT1A1 and SULT1A2 Allele Frequencies in Caucasian, Chinese, and African American Subjects. Pharmacogenetics, In Press.

Kelada SN, Kardia SLR, Walker AH, Wein AJ, Malkowicz SB, Rebbeck TR (2001) The Glutathione S-Transferase-m (GSTM1) and -q (GSTT1) Genotypes in the Etiology of Prostate Cancer: Gene-Environment Interactions with Smoking. Cancer Epidemiology Biomarkers and Prevention, in Press.

Turner BC, Krajewski S, Krajewski M, Takayama S, Grumbs AA, Carter D, Rebbeck TR, Haffty BG, Reed JC (2001) BAG-1: A novel biomarker predicting long-term survival in early stage breast cancer. Journal of Clinical Oncology, In press.

Nathanson KL, Omaruddin R, Malkowicz SB, Rebbeck TR (2001) An intronic variant in PTEN is not Associated with Prostate Cancer Risk. Cancer Epidemiology, Biomarkers and Prevention, In Press.